Leukemia Research
Volume 27, Issue 1 , Pages 5-12 , January 2003

Factors influencing the collection of peripheral blood stem cells in patients with acute myeloblastic leukemia and non-myeloid malignancies

Received 17 December 2001 ,Accepted 9 April 2002.

References 

  1. Gratwohl A, Passweg J, Baldomero H, Hermans J. Blood and marrow transplantation activity in Europe 1997: European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 1999;24:231
  2. Alegre A, Tomas JF, Martı́nez-Chamorro C, Gil-Fernandez JJ, Fernández-Villalta MJ, Arranz R, et al.  Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF versus G-CSF alone. Bone Marrow Transplant. 1997;20:211
  3. Desikan KR, Barlogie B, Jagannath S, Vesole DH, Siegel D, Fassas A, et al.  Comparable engraftment kinetics following peripheral blood stem cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma. J. Clin. Oncol. 1998;16:1547
  4. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, et al.  Factors that influence collection and engraftment of autologous peripheral blood stem cells. J. Clin. Oncol. 1995;13:2547
  5. Watts MJ, Sullivan AM, Jamieson E, Pearce R, Fielding A, Devereux S, et al.  Progenitor cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor cell quantity and quality and factors predictive for these parameters in 101 pre-treated patients with malignant lymphoma. J. Clin. Oncol. 1997;15:535
  6. Schwartzberg LS, 1993. Peripheral blood stem cell mobilization in the outpatient setting. In: Wunder EW, Hénon PR, editors. Peripheral blood stem cell autograft. Heidelberg: Springer, 1993. 177 p.
  7. Moskowitz CH, Glassman JR, Wuest D, Maslak P, Reich L, Gucciardo A, et al.  Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma. Clin. Cancer Res. 1998;4:311
  8. Haas R, Möhle R, Frühauf S, Goldschmidt H, Witt B, Flentje M, et al.  Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood. 1994;83:3787
  9. Weaver CH, Schwartzberg LS, Birch R, Greco FA, Rhinehart S, Hainsworth J, et al.  Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide and granulocyte colony-stimulating factor: an analysis of 497 patients. Transfusion. 1997;37:896
  10. Dreger P, Klöss M, Petersen B, Haferlach T, Löffler H, Loeffler M, et al.  Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood. 1995;86:3970
  11. Sautois B, Fraipont V, Baudoux E, Fassotte MF, Hermanne JP, Jérusalem G, et al.  Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields. Haematologica. 1999;84:342
  12. Schlenk RF, Dohner H, Pforsich M, Benner A, Fischer K, Hartmann F, et al.  Successful collection of peripheral blood progenitor cells in patients with acute myeloid leukaemia following early consolidation therapy with granulocyte colony-stimulating factor-supported high-dose cytarabine and mitoxantrone. Br. J. Haematol. 1997;99:386
  13. Jowitt SN, Chang J, Morgenstern GR, Howe T, Ryder WD, Testa NG, et al.  Factors which affect the CFU-GM content of the peripheral blood haemopoietic progenitor cell harvests in patients with acute myeloid leukaemia. Br. J. Haematol. 1998;100:688
  14. Sanz MA, de la Rubia J, Sanz GF, Martı́n G, Martı́nez J, Jarque I, et al.  Busulfan plus cyclophosphamide followed by autologous blood stem cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution. J. Clin. Oncol. 1993;11:1661
  15. de la Rubia J, Sanz GF, Martı́n G, Martı́nez J, Cervera J, Solves P, et al.  Autologous blood stem cell transplantation for acute myeloblastic leukemia in first complete remission: intensification therapy before transplantation does not prolong disease-free survival. Haematologica. 1999;84:125
  16. Heil G, Hoelzer D, Sanz MA, Lechner K, Liu Ying JA, Papa G, et al.  A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia: The International Acute Myeloid Leukemia Study Group. Blood. 1997;90:4710
  17. de la Rubia J, Sanz MA. Técnicas para la movilización y recolección de células hematopoyéticas. Sangre. 1991;36:181
  18. Iscove NN, Senn JS, Till JE, McCulloch EA. Colony formation by normal and leukemic human marrow cells in culture: effect of conditioned medium from human leukocytes. Blood. 1971;37:1
  19. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry: International Society of Hematotherapy and Graft Engineering. J. Hematother. 1996;5:213
  20. Pettengell R, Testa NG, Swindell R, Crowther D, Dexter TM. Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin’s lymphoma. Blood. 1993;82:2239
  21. Stewart DA, Guo D, Morris D, Poon MC, Ruether BA, Jones AR, et al.  Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens. Bone Marrow Transplant. 1999;23:111
  22. Marit G, Thiessard F, Faberes C, Cony-Makhoul P, Boiron JM, Bernard P, et al.  Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric study. Leukemia. 1998;12:1447
  23. Watts MJ, Leverett D, Sullivan AM, Peniket AJ, Perry AR, MacMillan A. A comparison of ESHAP + G-CSF versus cyclophosphamide (1.5 g/m2) + G-CSF for PBSC mobilization in pre-treated lymphoma patients: a matched pair analysis. Blood. 1996;88:396a; [abstract 1571]
  24. Desikan KR, Barlogie B, Jagannath S, Vesole DH, Siegel D, Fassas A, et al.  Comparable engraftment kinetics following peripheral-blood stem cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma. J. Clin. Oncol. 1998;16:1547
  25. Zeller W, Guttensohn K, Stockschläder M, Dierlamm J, Kröger N, Koehne G, et al.  Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin’s disease, non-Hodgkin’s lymphoma and cancer of the testis. Bone Marrow Transplant. 1996;17:709
  26. Kröger N, Zeller W, Fehse N, Hassan HT, Krüger W, Gutensohn K, et al.  Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patients. Br. J. Haematol. 1998;102:1101
  27. Weaver CH, Birch R, Greco FA, Schwartzberg L, McAneny B, Moore M, et al.  Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim. Br. J. Haematol. 1998;100:338
  28. Ketterer N, Salles G, Moullet I, Dumontet C, ElJaafari-Corbin A, Tremisi P, et al.  Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br. J. Haematol. 1998;103:235
  29. Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L, et al.  Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood. 1995;85:588
  30. Gertz MA, Lacy MQ, Inwards DJ, Pineda AA, Chen MG, Gastineau DA, et al.  Factors influencing platelet recovery after blood cell transplantation in multiple myeloma. Bone Marrow Transplant. 1997;20:375
  31. Kotasek D, Shepherd KM, Sage RE, Dale BM, Norman JE, Charles P, et al.  Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant. 1992;9:11
  32. McQuaker IG, Haynes AP, Stainer C, Anderson S, Russell NH. Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. Br. J. Haematol. 1997;98:228
  33. Mauch P, Constine L, Greenberger J, Knospe W, Sullivan J, Liesveld JL, et al.  Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1995;31:1319
  34. Drake M, Ranaghan L, Morris TC, Nolan L, Desai ZR, Irvine AE, et al.  Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system. Br. J. Haematol. 1997;98:745
  35. Reiffers J. Peripheral blood stem cell transplantation in acute myeloid leukemia: the experience of the Bordeaux Group. Stem Cells. 1995;13:19
  36. Linker CA, Ries CA, Damon LE, Sayre P, Navarro W, Rugo HS, et al.  Autologous stem cell transplantation for acute myeloid leukemia in first remission. Biol. Blood Marrow Transplant. 2000;6:50
  37. Chang J, Geary CG, Testa NG. Long-term bone marrow damage after chemotherapy for acute myeloid leukaemia does not improve with time. Br. J. Haematol. 1990;75:68
  38. Carlo-Stella C, Tabilio A, Regazzi E, Garau D, La Tagliata R, Trasarti S, et al.  Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. Bone Marrow Transplant. 1997;20:465
  39. Straetmans N, Herman P, Van Bockstaele DR, Michaux L, Hagemeijer A, Ferrant A. Haemopoietic defect and decreased expansion potential of bone marrow autografts from patients with acute myeloid leukaemia in first remission. Br. J. Haematol. 1998;101:571
  40. Teshima T, Harada M, Takamatsu Y, Makino K, Taniguchi S, Inaba S, et al.  Cytotoxic drug and cytotoxic drug/G-CSF mobilization of peripheral blood stem cells and their use for autografting. Bone Marrow Transplant. 1992;10:215
  41. Marit G, Boiron JM, Reiffers J. Acute myeloid leukaemia. In: Reiffers J, Goldman JM, Armitage JM, editors. Blood stem cell transplantation. UK: Martin Dunitz Ltd., 1998. 91 p.
  42. To LB, Haylock DN, Kimber RJ, Juttner CA. High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation. Br. J. Haematol. 1984;58:399
  43. Reid CD, Kirk A, Muir J, Chanarin I. The recovery of circulating progenitor cells after chemotherapy in AML and ALL and its relation to the rate of bone marrow regeneration after aplasia. Br. J. Haematol. 1989;72:21
  44. Cantin G, Marchand-Laroche D, Bouchard MM, Leblond PF. Blood-derived stem cell collection in acute non-lymphoblastic leukemia: predictive factors for a good yield. Exp. Hematol. 1989;17:991
  45. Szer J, Juttner CA, To LB, Bradstock KF, Sage RE, Enno A, et al.  Post-remission therapy for acute myeloid leukemia with blood-derived stem cell transplantation: results of a collaborative phase II trial. Int. J. Cell Clon. 1992;10:114
  46. Martı́n C, Torres A, León A, Rubio V, Alvarez MA, Herrera C, et al.  Autologous peripheral blood stem cell transplantation (PBSCT) mobilized with G-CSF in AML in first complete remission: role of intensification therapy in outcome. Bone Marrow Transplant. 1998;21:375
  47. Reichle A, Hennermann B, Meidenbauer N, Zaiss M, Bross KJ, Andreesen R. Peripheral blood stem cell transplantation (PBSCT) during consolidation treatment of the novo acute myelogenous leukemia. Blood. 1996;88:287b; [abstract 3874]
  48. Armitage S, Hargreaves R, Samson D, Brennan M, Kanfer E, Navarrete C. CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant. 1997;20:587
  49. Yu J, Leisenring W, Bensinger WI, Holmberg LA, Rowley SD. The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield. Transfusion. 1999;39:442

PII: S0145-2126(02)00068-1

Leukemia Research
Volume 27, Issue 1 , Pages 5-12 , January 2003

Article Tools

* Image Usage & Resolution